Deepinder K. Dhaliwal, MD, L.Ac, is a licensed acupuncturist and founded the Center for Integrative Eye Care at the University of Pittsburgh to systematically research alternative treatments for eye disease.
Dr. Dhaliwal holds leadership positions in the Cornea Society, the International Society of Refractive Surgery of the American Academy of Ophthalmology, and the Eye and Contact Lens Association/CLAO. She is a recognized expert in her field and teaches corneal and refractive surgical techniques to other ophthalmologists globally. In addition to teaching and research activities, she has authored several book chapters, numerous journal articles, and serves on the editorial board of several ophthalmology journals.
- University of Utah, Refractive Surgery, Cornea/External Disease, and Anterior Segment Surgery Fellowship
- University of Pittsburgh Medical Center, Ophthalmology Residency
- Evanston Hospital (Northwestern University/McGaw Medical Center), Transitional Medicine Internship
- Northwestern University Medical School, MD
- Northwestern University, BSM, Honors Program in Medical Education
Education & Training
Double Povidone-Iodine 5% Preparation Before Cataract Surgery for Endophthalmitis Prevention. Odden JL, Winters J, Zlotcavitch L, Mammen A, Romanowski EG, Shanks RMQ, Dhaliwal DK. Eye Contact Lens. 2025 Jan 21. doi: 10.1097/ICL.0000000000001164.
Severe Corneal Flattening After Endothelial Keratoplasty: Collagen Compaction Syndrome. Moloney G, Al-Zanki S, Burgos-Blasco B, Fadaifard Martinez M, Bujak M, Dhaliwal DK. Cornea. 2024 Nov 7. doi: 10.1097/ICO.0000000000003752
A Full Good Manufacturing Practice-Compliant Protocol for Corneal Stromal Stem Cell Cultivation. Santra M, Hsu YS, Khadem S, Radencic S, Funderburgh ML, Sawant OB, Dhaliwal DK, Jhanji V, Yam GHF. Bio Protoc. 2024 Sep 20;14(18):e5074. doi: 10.21769/BioProtoc.5074. eCollection 2024 Sep 20.
Embracing Independence: A New Chapter for the International Society of Refractive Surgery. Ambrósio R Jr, Dhaliwal DK. J Refract Surg. 2024 Feb;40(2):e72. doi: 10.3928/1081597X-20240112-01. Epub 2024 Feb 1.
Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring. Santra M, Geary ML, Rubin E, Hsu MYS, Funderburgh ML, Chandran C, Du Y, Dhaliwal DK, Jhanji V, Yam GH. Stem Cell Res Ther. 2024 Jan 8;15(1):11. doi: 10.1186/s13287-023-03626-8.